Date: 14 July 2022

Country: Webinar

Date: Thursday 14 July 2022
Time: 17:00 - 18:15 CET (16:00 - 17:15 BST)

Click here to register

Programme & Speakers:
Introduction - Toni Seppälä (Finland)
MSI Biology and Pathology - John Burn (UK) 
Implications of MSI for surgeons - Gabriela Möslein (Germany)
Oncological implications: when is immunotherapy an option? - Kai-Keen Shiu (UK) 
Discussions and Live Q&A


Des Winter (Ireland)

Toni Seppälä (Finland)

Who is this event intended for? 
Colorectal surgeons and those interested in personalised therapy and hereditary cancer

What is the benefit of attending?

Understanding the importance of microsatellite instability testing.


Supported by the European Hereditary Tumour Group 

EHTG Logo with text

Sponsored by Promega 

promega logo 01


Click here to register

ESCP Affiliates